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A B S T R A C T
Objective: To quantify the expression of IL-18 mRNA and protein in the chorioamniotic membranes of
pregnant women with PPROM and correlate expression with histological chorioamnionitis.
Study design: A case control study that included 42 pregnant women not in labor in the following groups:
PPROM (n = 28) and controls with intact membranes submitted to selective cesarean section at term
(n = 14). Expression of IL-18 mRNA in chorioamniotic membranes was determined by real-time
polymerase chain reaction, and IL-18 protein expression was measured by western blot. Histopatholog-
ical analyses and immunolocalization of IL-18 by immunohistochemistry were also performed. Analyses
were performed using the Mann–Whitney or Fisher’s exact tests and the group effect was considered
signiﬁcant if the adjusted p-values were <0.05 and the magnitude of change was greater than 2-fold for
mRNA expression.
Results: IL-18 mRNA was present in 100% of samples and no difference in expression was observed
between term vs. PPROM membranes (fold-change 0.12; p = 0.88). In the PPROM group, no difference was
observed in IL-18 mRNA regarding gestational age (fold-change 0.11; p = 0.42) or the presence of
histological chorioamnionitis (fold-change 0.26; p = 0.15). ProIL-18 was present in all samples. IL-18 was
immunolocalized to amnion, chorion and decidua cells, with intense immunohistochemical staining at
the choriodecidual junction.
Conclusion: Chorioamniotic membranes are sources of IL-18 mRNA and proIL-18, and their expression is
unrelated to PPROM or histological chorioamnionitis.
 2012 Elsevier Ireland Ltd. 
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Rupture of membranes (ROM) is a physiological process
occurring during labor. When it occurs spontaneously before 37
weeks of gestation in the absence of labor, it is referred to as
preterm prelabor rupture of membranes (PPROM) [1], and is one of
the major causes of prematurity [2]. Prelabor rupture can result
from various mechanisms, including bacterial invasion of the
amniotic cavity and histological chorioamnionitis [3], physiologi-
cal membrane weakening, diminished repair potential and in utero
stretch forces with altered physical properties, which induce
transcription and activation of proteins that promote apoptosis* Corresponding authors at: Faculdade de Medicina de Botucatu, UNESP – Univ
Estadual Paulista, Departamento de Patologia, Distrito de Rubia˜o Ju´nior, CEP:
18618-970, Botucatu, Sa˜o Paulo, Brazil. Tel.: +55 (14) 3811 6238; fax: +55 14 3815
2348.
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Open access under the Elsevier OA license.and remodeling of the chorioamniotic membranes [4]. Recent
studies have demonstrated that fetal membranes from women
with PPROM presented a higher apoptotic index [5] and that an
increase in apoptosis occurs in the presence of histological
chorioamnionitis compared with its absence in PPROM [6] and
term [7] membranes.
The two major pathways that trigger apoptosis in fetal
membranes during PPROM are p53 and Fas-FasL/TNF-TNFR p55
(TNFR1) mediated pathways [8–10]. These activators can incite
inﬂammatory changes, with fetal membrane degradation and
weakening [11]. Moreover, apoptosis can also promote matrix
degrading enzyme activation, promoting membrane degradation
and rupture [8]. Both mechanisms result in the activation of
nuclear factor (NF)-kB, a transcription factor that is involved in the
synthesis and regulation of proinﬂammatory cytokines and
prostaglandins [12–14].
IL-18 is a novel multifunctional cytokine that paradoxically
participates in the regulation of both Type 1 and Type 2 helper T
cell (Th1 and Th2) responses and increases both innate and
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appears to act in association with IL-12 in inducing IFN-g [17,18].
Moreover, IL-18 has the ability to induce the synthesis of TNF-a, IL-
1b, IL-8, and other cytokines, as well as to activate effector cells
and molecules, like NF-kB [19]. IL-18 shares structural similarities
with IL-1b and is produced as a 24-kD inactive precursor lacking a
signal peptide (proIL-18) [20,21]. This form of IL-18 requires
cleavage to an active cytokine by the IL-1b-converting enzyme
(caspase-1), an intracellular cysteine protease [22,23].
IL-18 is expressed by human gestational tissues [24,25], but
studies of IL-18 in relation to its role in pregnancy have been
inconclusive. Some investigations showed an increase in serum
and amniotic ﬂuid (AF) IL-18 levels throughout pregnancy and
during labor [26,27]. Ekelund et al. [28] reported that serum from
women delivering before 34 weeks’ gestation showed signiﬁcantly
lower levels of IL-18 compared with women delivering after 34
weeks. Conversely, Daskalakis et al. [29] demonstrated recently
that AF from preterm deliveries contained signiﬁcantly higher
concentrations of IL-18 compared with term pregnancies. In
noninfected women with PPROM, higher AF levels of IL-18 have
been detected compared with women who underwent preterm
labor with intact membranes or term delivery [25].
Considering that proinﬂammatory cytokine-induced collagen
remodeling and apoptosis correlate directly with fetal membrane
physical weakness [11] and that IL-18 has proinﬂammatory
properties, the objective of the present study was to investigate
the expression of IL-18 mRNA and protein in chorioamniotic
membranes in relation to PPROM and chorioamnionitis.
2. Materials and methods
This was a case control study designed to evaluate the
expression of IL-18 in chorioamniotic membranes from pregnant
women with PPROM. All the patients studied were admitted to the
Obstetrics Unit of the Hospital of Botucatu Medical School, located
in the central region of the State of Sa˜o Paulo, Brazil, in 2008. From
a total of 1560 deliveries, 96 (6.2%) presented PPROM. Incomplete
labor and delivery information, difﬁculties in sample collection
and exclusion criteria resulted in the inclusion of 28 women with
PPROM without labor and 14 control pregnant women at >37
weeks of gestation. All these women were scheduled for an elective
cesarean section for the following indications: previous cesarean
sections or breech presentation. None of the women at term were
in labor or presented with rupture of membranes prior to surgery.
Women with multiple pregnancies, preeclampsia, diabetes, fetal
anomalies and placenta previa were excluded. Gestational age was
calculated from the ﬁrst day of the last menstruation and/or from
the ﬁrst trimester ultrasound.
PROM was diagnosed by sterile speculum examination con-
ﬁrming pooling of amniotic ﬂuid in the vagina, positive nitrazine
paper test, positive fern test and fetal cells in cervicovaginal
secretion, and was deﬁned according to the Brazilian Ministry of
Health guidelines, available at: http://portal.saude.gov.br/portal/
arquivos/pdf/Manual%20Puerperio%202006.pdf. The Human Re-
search Ethics Committee of the institution approved the study and
written informed consent was obtained from all participants.
Chorioamniotic membrane samples were immediately
obtained after placental delivery and stored in RNA later1 solution
at 80 8C until RNA extraction and IL-18 expression analysis.
Additional samples were ﬁxed in 10% formalin, embedded in
parafﬁn, sectioned and stained with hematoxylin and eosin for
histological evaluation and IL-18 and caspase-1 immunolocaliza-
tion by immunohistochemistry. Other chorioamniotic samples
were snap frozen in liquid nitrogen and stored at 80 8C until
protein expression analysis.Total RNA was extracted from tissue samples stored in RNA later
using a commercial RNA isolation kit (Illustra RNAspin Mini
Isolation Kit (GE Healthcare)). A total of 1.0 mg of RNA from each
sample were reverse transcribed using the High-Capacity cDNA
Archive Kit (Applied Biosystems, Foster City, CA, USA), in
accordance with the manufacturer’s recommendations. The qPCR
reactions were assembled based on the TaqMan Universal PCR
Master Mix protocol (Applied Biosystems), using GAPDH for
quantiﬁcation of the housekeeping gene and the TaqMan gene
expression assay (Hs 00155517_m1) for IL-18 mRNA. Data were
collected by the ABI Prism 7300 Sequence Detection System
(Applied Biosystems). The results are expressed as the ratio of IL-18
to GAPDH expression and the threshold cycle number (CT) was
used to determine relative IL-18 mRNA expression, using the ddCT
method [30]. A mix from some studied samples was used as a
calibrator on all plates to account for eventual plate effects.
Relative mRNA expression for IL-18 is given as relative folds,
increased or decreased, between the studied groups.
For immunohistochemical analysis, eight micron-thick sections
from formalin-ﬁxed, parafﬁn-embedded tissue blocks were
mounted on slides, dried at 37 8C for 24 h and subjected to
deparafﬁnization followed by antigen-retrieval by boiling in
TrilogyTM solution (Cell Marque, Hot Springs, AR) for 30 min.
Sections were then immediately transferred to fresh hot TrilogyTM
solution in a second staining dish for 5 min and washed in PBS
buffer (Biocare Medical, Concord, CA, USA). Before the primary
antibodies for IL-18 [mouse monoclonal anti-human IL-18
(1:12,000) (MBL, Naka-ku, Nagoya, Japan)] or caspase-1 [mouse
monoclonal anti-human caspase-1 (1:1200) (ab54932, Abcam Inc.,
Cambridge, MA, USA)] were applied, endogenous peroxidase
activity was quenched with Peroxidazed 1 (Biocare Medical) for
10 min at room temperature and sections were washed again in
PBS buffer. The primary antibodies were applied for 3 h at room
temperature. Staining was performed using the MACH 4 universal
detection system (Biocare Medical), in accordance with the
manufacturer’s recommendations, and was visualized with DAB
(3,30-diaminobenzidine tetrahydrochloride) (Biocare Medical).
Sections were counterstained with Harris hematoxylin. Negative
controls were performed for each specimen, in which sections
were incubated without the primary monoclonal antibodies.
Sections from normal human prostate and pancreatic tissue were
obtained from the Department of Pathology Archives at the
Botucatu Medical School and applied as positive and negative
controls for caspase-1 expression [31,32], respectively.
Snap frozen chorioamniotic membranes samples were lysed in
a lysis buffer [PBS, 1% (v/v) Nonidet P-40, 0.5% (w/v) sodium
deoxycholate, 0.1% sodium dodecyl sulfate (SDS) and protease
inhibitor (10 mL/mL, Amersham1)]. The insoluble material was
then removed by centrifugation at 1500  g for 20 min at 4 8C. The
concentration of protein in each cell lysate was determined using a
BCA protein assay kit (Bio-Rad Laboratories, Inc.) with bovine
serum albumin (BSA) as the standard. An identical amount of
protein (30 mg) from each sample was loaded onto a 10% SDS-PAGE
gel and electrophoresed at 200 V. The resolved proteins were
transferred to an Hybond-P membrane (Amersham Biosciences, GE
Healthcare Ltd., Chalfont St. Giles, Bucks., UK) using a wet transfer
apparatus (Bio-Rad Laboratories1). The membranes were blocked
in Tris-Buffered Saline (TBS) containing 0.1% Tween 20 (TBS-T) and
5% skim milk for 1 h at room temperature. Blots were incubated
with anti-IL-18 [mouse monoclonal anti-human IL-18 (1/1000
dilution) (MBL, Naka-ku, Nagoya, Japan)] and anti-b-actin speciﬁc
primary antibody [(1:6000) mouse monoclonal anti-human beta-
actin (1/6000 dilution) (ab6276, Abcam Inc., Cambridge, MA, USA)]
at 4 8C and shaken overnight. Blots were washed three times with
TBS-T and then incubated with peroxidase-conjugated goat anti-
mouse IgG secondary antibody [(1/5000 dilution) SAB – Signalway
Table 1
Demographic and obstetrics characteristics of study subjects.
Term (n = 14) PPROM (n = 28) p
Maternal age (years)a 30 (27–37) 23.5 (19–29.5) 0.007
Ethnicityb
White 11 (78.6) 26 (92.8) 0.31
Non-white 3 (21.4) 2 (7.2)
Smoking habitsb
Yes 2 (14.3) 2 (7.2) 0.59
No 12 (85.7) 26 (92.8)
Gestational age at delivery (weeks, days)a 38w4d (38w to 38w6d) 34w3d (33w to 35w4d) <0.0001
Gravidab
1 1 (7.1) 17 (60.7) <0.001
>1 13 (92.9) 11 (39.3)
Histological chorioamnionitis
Yes – 12 (42.8) 0.003
No 14 (100.0) 16 (57.2)
Prior adverse gestational outcomesb
Yes 7/13 (53.8) 5/11 (45.5) 1.000
No 6/13 (46.2) 6/11 (54.5)
a Median (interquartile range); Mann–Whitney test.
b n(%); Fisher’s exact test.
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using chemiluminescence reagents ECL Plus Western Blotting
Detection System (AmershamTM), in accordance with the manu-
facturer’s recommendations. The signals were captured by the
Alpha Innotech FluorChem1 FC2 Imager.
Statistical analyses were performed with SigmaStat Software
version 3.1. After checking for data normality, maternal age,
gestational age at delivery and IL-18 mRNA concentrations were
compared between the groups studied using the Mann Whitney
test. Ethnicity, smoking habits, parity, previous pregnancy
complications and histological chorioamnionitis were compared
using Fisher’s exact test. A p value <0.05 was considered to be
statistically signiﬁcant.Fig. 1. Box plot representing IL-18 mRNA expression in chorioamniotic membranes, anal
(fold-change 0.12; p = 0.88). (B) IL-18 mRNA in relation to gestational age (<34 weeks
p = 0.42). (C) IL-18 mRNA in relation to histological chorioamnionitis in the PPROM gr3. Results
The sociodemographic and clinical characteristics of the study
population are shown in Table 1. Maternal age was lower in the
PPROM group compared with term women. Gravida and the
presence of histological chorioamnionitis were statistically differ-
ent between the groups studied, while ethnicity, smoking habits
and previous pregnancy complications were similar.
IL-18 mRNA was present in 100% of the samples, demonstrating
constitutive gene expression in chorioamniotic membranes. No
statistical difference in the relative fold expression of IL-18 was
observed in the PPROM group vs. the term group (Fig. 1A). A similar
ﬁnding was observed regarding gestational age in the PPROMyzed by real time PCR. (A) Comparison between term pregnancies vs. PPROM group
 of gestation and >34 weeks of gestation) in the PPROM group (fold-change 0.11;
oup (fold-change 0.26; p = 0.15). Mann–Whitney test.
Fig. 2. Immunohistochemical detection of interleukin (IL)-18 in chorioamniotic membranes from the PPROM group. Negative control, sections were incubated without
monoclonal anti-human IL-18 (A). Sections incubated with anti-human IL-18 in the presence (B) or absence (C) of histological chorioamnionitis (original magniﬁcation of all
images, 400).
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and between 34 and 36 weeks’ gestation (Fig. 1B); and regarding
the presence or absence of histological chorioamnionitis (Fig. 1C).
Samples subjected to immunohistochemistry showed the
presence of IL-18 localized in amnion, chorion and decidua cells
(Fig. 2). The staining was most intense at the area of the
choriodecidual junction.
In order to quantify IL-18 levels in chorioamniotic membranes,
western blot was performed. Only the 24 kDa immunoreactive
band corresponding to the immature form of IL-18 (proIL-18) was
detected. The 18 kDa mature bioactive form was not observed
(Fig. 3), perhaps due to the fact that predominantly intracellular
material was being analyzed. However, due to the absence of
mature IL-18, the samples were also evaluated for the presence of
the enzyme caspase-1, which creates mature IL-18 from its
precursor. Discrete immunoperoxidase staining of caspase-1 was
observed in amniotic, chorionic and decidual cells (Fig. 4).
4. Comment
The present study demonstrates that chorioamniotic membranes
from pregnant women not in labor are constitutive producers ofFig. 3. Western blot analysis of interleukin (IL)-18 in chorioamniotic membranes using 
10 ng, 18 kDa). Lanes 2–8: chorioamniotic membranes samples from the PPROM group
group (7–8), showing the characteristics bands of proIL-18 (24 kDa). Lane 9: prestaineIL-18 mRNA and that the extent of this expression is unrelated to the
presence or absence of PPROM and/or histological chorioamnionitis.
Furthermore, the precursor proIL-18 protein was detected within
the chorioamniotic membranes together with caspase-1. Presum-
ably mature IL-18 was identiﬁed at the choriodecidual junction. We
cannot exclude the possibility that small amounts of bioactive IL-18,
below the detection limit of Western blot analysis, may have been
present within the chorioamnotic membrane preparations. The
antibody used to measure IL-18 in this study recognized both the
mature and unprocessed forms. A prior publication by Gotsch et al.
[33] concluded that caspase-1 levels in amniotic ﬂuid were absent at
mid-trimester and were highest in samples obtained from women in
labor at term. Thus, production of bioactive IL-18 may only occur to a
limited extent prior to parturition. Serum IL-18 concentrations were
lower in women in preterm labor compared with women in term
labor [28]. Similarly, reduced amniotic ﬂuid IL-18 levels were
identiﬁed in women who delivered preterm [34]. Although caspase-
1 cleavage of proIL-18 is not exclusive and recent reports suggest
other proteases, such as proteinase 3 [35] and granzyme B [36], also
generate biological activity from precursor IL-18, little is known
regarding the expression and regulation of these proteins in
gestational tissues.monoclonal anti-human IL-18. Lane 1: recombinant IL-18 protein (positive control,
 in the absence (2–4) and presence (5–6) of chorioamnionitis and from the control
d protein marker (20 and 15 kDa).
Fig. 4. Immunohistochemical detection of caspase-1 in chorioamniotic membranes. Negative controls from prostate tissue and chorioamniotic membranes, sections were
incubated without the monoclonal antibody anti-human caspase-1 (A and B, respectively). Sections from prostate and pancreatic tissues incubated with antibody anti-
human IL-18 (C and D, respectively). Chorioamniotic membranes from the PPROM group incubated with anti-human caspase-1 (E and F) (original magniﬁcation of all images,
400).
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the induction of prelabor rupture of the chorioamniotic mem-
branes nor is it a factor in chorioamnionitis-related membrane
disruption, rather that IL-18 is activated and functional during
term labor and participates in the parturition process. Previous
studies demonstrated no relationship between the amniotic ﬂuid
concentrations of IL-18 and PPROM [26,27]. In addition, Amash
et al. [24] showed the levels of IL-18 in the amnion, chorion and
placenta from uncomplicated term pregnancies were unchanged
in the presence of LPS. A possible function for IL-18 prior to
parturition can be implied from experiments in mice. Deletion of
the gene coding for IL-18 was shown to result in a markedly
elevated rate of fetal loss compared to intact control mice [37].
Further investigations are required to clarify the molecular
mechanisms involved in IL-18 activation at the maternal–fetal
interface, to evaluate protease and inﬂammasome activity in
chorioamniotic membranes from women not in labor and to deﬁne
the biological roles of IL-18 following term labor initiation.Acknowledgments
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